This paper compares health care systems. It looks beyond normal academic, political, or journalistic rhetoric, by exactly sticking to facts, i.e. empirical data (in particular data provided by the WHO) and comprehensive case study analyses. The paper finds that a number of myths and common...

This paper focuses on the question: Does public or private control of health care lead to greater healthcare system efficiency? The data analysis demonstrates a curvilinear relationship between government control over health care and health care system inefficiency and that, as a result, a...

In recent years, consumer choice has become an important element of public policy. One reason is that consumers differ in their tastes and needs, which they can express most easily through their own choices. Elements that strengthen consumer choice feature prominently in the design of public...

The ACA requires insurers to provide cost-sharing reductions (CSRs) to low-income consumers on the marketplaces. We link 2013-2015 All-Payer Claims Data to 2004-2013 administrative hospital discharge data from Utah and exploit policy-driven differences in the value of CSRs that are solely...

Growth in the number of days between an appointment request and the actual appointment reduces demand. Although such waiting times are relatively low in the US, current policy initiatives could cause them to increase. We estimate multiple-equation models of physician utilization and insurance...

The business model used by Congress to pay for Social Security, Medicare and national debt is our costliest federal mandate. Because they run a national retirement plan without using compound interest, Congress makes us pay TWELVE dollars to do a ONE-dollar job. This business model is the root...

The United States has state of the art technology and world renowned expertise in medical treatment, yet in terms of healthcare it shows a dramatically poor performance in relation to the other industrialized countries. This situation is surprising, since one would expect that a free market...

This paper examines the tradeoffs of monitoring for wasteful public spending. By penalizing unnecessary spending, monitoring improves the quality of public expenditure and incentivizes firms to invest in compliance technology. I study a large Medicare program that monitored for unnecessary...

This study examines the relationship between pharmaceutical R&D and health care expenditures, distinguishing between the short- and long-run impacts. To measure these relationships quantitatively, we focus on patents as a key factor driving the costs of pharmaceuticals, and develop a structured...

The United States has state of the art technology and world renowned expertise in medical treatment, yet in terms of healthcare it shows a dramatically poor performance in relation to the other industrialized countries. This situation is surprising, since one would expect that a free market...